Probiotics on the Label: CFU, Strains, and What the Evidence Actually Supports

A probiotic label can look unusually precise: a long Latin name, an alphanumeric strain code, and a promise of 20 billion CFU. That precision is useful only when it answers the question you actually have. A higher CFU number does not automatically mean a better product, and a product called “probiotic” has not automatically been shown to help every gut symptom.

The practical way to read these products is to separate four things: the microorganism, its strain, the viable count at the date you will use it, and the specific outcome studied in people. That distinction helps shoppers avoid paying for a generic “gut health” promise when the label does not identify what is inside or what it is intended to do.

Start with the question you are trying to answer

Probiotics are live microorganisms that can provide a health benefit when taken in adequate amounts. They are found in some fermented foods, added to certain foods, and sold in capsules, powders, liquids, and other formats. The definition is narrower than the casual phrase “good bacteria.” A living microbe is not automatically a probiotic simply because it appears in yoghurt, kombucha, or a supplement.

Before comparing bottles, name the reason you are considering one. Are you looking for a food you enjoy? Are you trying to make sense of a product recommended alongside an antibiotic? Are you responding to ongoing bloating, pain, diarrhoea, constipation, or a diagnosed bowel condition? Those are different situations, and they should not all lead to the same purchase.

A useful first pass is:

• For everyday eating, choose foods you like and can include safely in your usual diet.
• For a particular health outcome, look for a product that names the strain and links it to that outcome with human research.
• For persistent, severe, or unexplained symptoms, seek clinical advice rather than treating the supplement aisle as a diagnostic tool.
• For children, pregnancy, immune suppression, serious illness, or hospital care, ask a doctor, pharmacist, or dietitian before starting a product.

This is not a rejection of probiotics. It is a way to put the evidence ahead of the package design. The NIH Office of Dietary Supplements notes that many commercial products have not been studied, so it can be difficult to know which ones have verifiable health benefits.

Probiotic, prebiotic, fermented food, and postbiotic are different terms

The vocabulary creates much of the confusion. A probiotic is a live microorganism with a demonstrated health benefit at an adequate amount. A prebiotic is generally a type of carbohydrate used as fuel by microorganisms in the gut. A synbiotic combines a prebiotic with live microorganisms. A postbiotic is a preparation of inanimate microorganisms or their components that has a health benefit.

These categories can overlap in a routine without being interchangeable. A high-fibre food can support gut health without containing a probiotic. A fermented food can contain live cultures without having a strain-specific probiotic claim. A capsule can contain a named probiotic strain without replacing the fibre, fluids, meals, movement, and medical care that may matter more for someone’s symptoms.

Yoghurt is a helpful example. It is made with live cultures such as Lactobacillus bulgaricus and Streptococcus thermophilus. Some yoghurts also contain added microorganisms from Bifidobacterium or the Lactobacillaceae family. Yet the NIH distinguishes fermented foods with live cultures from foods that contain probiotic microorganisms with proven benefits. Sourdough bread, many commercial pickles, kimchi, kombucha, sauerkraut, miso, and apple cider vinegar may be fermented, but fermentation alone is not a guarantee of a proven probiotic effect.

That does not make those foods poor choices. It simply prevents a label category from doing more work than it can. If you buy yoghurt because you enjoy it and it suits your diet, that is a sound food decision. If you are trying a probiotic for a defined outcome, the strain and evidence need to be visible.

The strain is the part of the name that changes the answer

A probiotic is identified by its genus, species, and strain designation. Take Lacticaseibacillus rhamnosus GG as an example. “Lacticaseibacillus” is the genus, “rhamnosus” is the species, and “GG” identifies the strain. A label that stops at a broad family name or simply says “Lactobacillus blend” gives less information than one that provides the full designation.

Why does this matter? The actions of probiotics can vary between species and even between strains of the same species. The NIH notes that some mechanisms are shared broadly, while others are species-specific or strain-specific. Research results from one strain cannot safely be copied across every other microbe with a similar name.

Taxonomy can make this look harder than it is. In 2020, the old Lactobacillus genus was reorganised, and some familiar organisms acquired new genus names. You might therefore see an older study refer to Lactobacillus rhamnosus GG while a newer label says Lacticaseibacillus rhamnosus GG. The relevant point is the full organism and strain code, not whether the front label uses an older familiar shorthand.

A better label has enough detail for you to search the exact strain. A weaker label asks you to accept a broad promise without telling you which organism is meant to deliver it. If a brand cites a study, check whether the study used the same strain, amount, formulation, and population. “Contains probiotics” is an ingredient statement. It is not evidence of a particular result.

“Probiotics are identified by their specific strain, which includes the genus, the species, the subspecies (if applicable), and an alphanumeric strain designation.” — NIH Office of Dietary Supplements, Probiotics: Health Professional Fact Sheet

CFU is a live count, not a score out of ten

CFU stands for colony-forming units. It estimates the number of viable microorganisms in a serving. Labels may show 1 × 10⁹ CFU for one billion or 1 × 10¹⁰ CFU for ten billion. These figures look like a ranking system, but they are not one.

The right amount depends on the exact strain, product, and purpose studied. The NIH says many products contain one to ten billion CFU per dose, while some contain 50 billion or more. It also states plainly that higher counts are not necessarily more effective. A product with 50 billion organisms is not automatically a more useful choice than one with one billion. It may be a different formulation for a different purpose, or it may simply be a larger number on the shelf.

Check whether the count is stated through the expiry or use-by date, rather than only at manufacture. Live microorganisms can decline during storage. A number that was true when a batch left the factory may not describe the product near the end of its shelf life. The International Scientific Association for Probiotics and Prebiotics advises listing total CFU, ideally for each strain, through the expiration date or use-by date.

Three label details are worth recording before you buy:

• The full genus, species, and strain designation for each microorganism.
• The CFU amount per serving and whether it applies at expiry rather than at manufacture.
• The serving size, use-by date, and storage instructions.

A number without a named strain is incomplete. A named strain without a viable count through expiry is also incomplete. The aim is not to find the largest number, but to find a label that makes a realistic evidence check possible.

Storage is part of what you are buying

Probiotics are living products, so storage instructions are not decorative fine print. Some need refrigeration. Others are formulated for room-temperature storage. The directions on the package should be followed from the shop to your kitchen, including any instruction about moisture, heat, or using the product before a certain date after opening.

This also changes how you compare a refrigerated product with a shelf-stable one. Refrigeration is not proof that a product is superior, and room-temperature storage is not proof that it is ineffective. They are different product designs. What matters is whether the manufacturer gives clear conditions and represents its viable count for the period it expects the product to be used.

Avoid creating a home experiment from the label. Leaving a product in a hot car, storing a refrigerated product in a warm cupboard, or taking it well past the expiry date makes the stated count less meaningful. The same applies to buying a large bottle because the price per capsule looks attractive when you do not expect to finish it before the use-by date.

For food, check the package language too. A yoghurt may say it contains live cultures. That tells you something useful about the product, but it does not by itself establish a clinical benefit. If the carton makes a specific claim, look for the named culture or strain and the conditions attached to the claim.

Evidence needs a condition, a population, and a comparator

Most probiotic marketing becomes vague at the point evidence matters. “Supports balance” and “helps the microbiome” do not specify who was studied, what symptom changed, how long the product was used, or what it was compared with. Those gaps matter because probiotic effects are not universal.

Antibiotic-associated diarrhoea is one area where the research is more specific than a general wellness claim. Antibiotics can disturb the intestinal microbiome, and the NIH cites reviews in which certain strains were associated with a lower risk of antibiotic-associated diarrhoea in particular populations. In its summary, the NIH notes that starting Lacticaseibacillus rhamnosus GG or Saccharomyces boulardii within two days of the first antibiotic dose may help reduce risk in children and adults aged 18 to 64. The outcome still depends on the antibiotic, strain, age, setting, and the person’s health.

That does not mean everyone prescribed antibiotics should independently add a probiotic. A pharmacist is the right person to ask about the medicine, timing, the individual’s medical situation, and whether the product under consideration matches the evidence. Do not change, delay, or stop a prescribed antibiotic because of a probiotic product.

For irritable bowel syndrome, the evidence is mixed and modest. The NIH describes reviews in which some probiotic products improved some symptoms, while identifying continuing uncertainty over the specific strain, dose, duration, and type of IBS most likely to respond. IBS also has symptoms that overlap with other conditions. A supplement trial should not replace assessment of bleeding, weight loss, fever, a new change in bowel habit, significant pain, or symptoms that keep returning.

For inflammatory bowel disease, the boundary is clearer. The American Gastroenterological Association recommends probiotics for ulcerative colitis or Crohn’s disease only in the context of a clinical trial. The NIH says there is no evidence that probiotics induce or maintain remission in Crohn’s disease, and the evidence for ulcerative colitis remains limited. A product sold for gut health is not a substitute for prescribed IBD treatment.

Acute infectious diarrhoea in children is another area with a documented, though inconsistent, pattern. Some reviews cited by the NIH found that certain probiotics shortened the duration of diarrhoea by around a day, while more recent large trials conducted in emergency departments in the United States and Canada found no meaningful benefit over placebo. The NIH notes that most episodes are self-limiting and that rehydration, not a supplement, remains the primary treatment. This is a useful case study in why a positive result from one country or setting does not automatically transfer everywhere; the population, the standard of care, and the strain used all shift the outcome.

Atopic dermatitis (eczema) research follows a similar shape. Several meta-analyses summarised by the NIH suggest that probiotic use during pregnancy and early infancy might modestly lower a child’s risk of developing atopic dermatitis, and that certain strains can slightly reduce symptom severity once a child has the condition. A 2018 Cochrane review of 39 trials in nearly 2,600 participants concluded that any reduction in standard severity scores was not clinically meaningful and did not support using probiotics to treat eczema. Two reputable reviews of the same general subject reaching different practical conclusions is common in this field, and it is exactly why a single marketing claim should never be read as settled science.

What research does and does not say about everyday “gut health”

The phrase “gut health” can cover digestion, bowel regularity, bloating, immunity, mood, food tolerance, and a sense of general wellbeing. That breadth makes it useful in conversation and imprecise on a product label. A person can feel better after changing several habits at once and still have no way to attribute the change to a particular capsule.

The NIH reports that there are no formal recommendations for or against probiotic use in healthy people. That is not the same as saying healthy people must avoid them. It means the decision should be proportionate. For someone who is well and curious, a short, carefully chosen trial may be reasonable after checking the label and safety considerations. For someone trying to solve a significant symptom, a generic blend is a weak substitute for assessment.

Set a narrow goal if you decide to trial a product. Record the start date, exact product, strain, amount, and the one symptom or outcome you want to observe. Keep other major changes as stable as practical. Review after the period supported by the product’s evidence or after a sensible agreed timeframe with a clinician. If there is no clear benefit, there is little reason to keep escalating the CFU count or adding several blends.

This approach has a second advantage: it prevents a supplement drawer from becoming a record of unresolved symptoms. If a product gives you more gas, discomfort, or another unwanted effect, stop and ask a health professional if it persists. For healthy people, side effects are usually minor and gastrointestinal, such as gas, but “usually” is not the same as “never.”

Who should not treat a probiotic as a casual purchase

Probiotics are generally unlikely to cause harm in healthy people, according to the NIH. The risk picture changes in some groups. The agency notes reports of bacteremia, fungemia, and other serious infections linked to probiotic use, mostly in people who were severely ill or immunocompromised.

The U.S. Food and Drug Administration issued a 2023 warning about probiotic products used in hospitalised preterm infants. It reported that these products may cause invasive, potentially fatal disease in this population. That is a hospital and specialist-care issue, not a reason to make decisions for a preterm infant from a supermarket label.

Use extra caution and seek professional advice before taking a probiotic if you:

• have a weakened immune system or are receiving immunosuppressive treatment;
• are seriously unwell, are in hospital, or have a central venous catheter;
• are considering a product for a preterm infant, a medically complex child, or an older person with significant illness;
• have a diagnosed gastrointestinal disease or are taking treatment for one; or
• are pregnant or breastfeeding and want a product for a specific health purpose.

There is no prize for self-managing a higher-risk situation. Take the product label or a photo of it to a pharmacist or clinician. The full strain name, the CFU figure, and the proposed reason for use are more helpful than saying you are taking “a gut supplement.”

Food first does not mean food claims cure disease

Foods can be a sensible place to begin because they fit into meals rather than adding another routine. Yoghurt, kefir, and other fermented foods may be enjoyable sources of live cultures. They also contribute other nutrients, energy, and, depending on the product, sugars and fats. Read them as foods, not as medical treatments.

For people who tolerate dairy, yoghurt can be one option. For people avoiding dairy, the label becomes especially important because plant-based fermented products vary widely in protein, added sugar, calcium fortification, and culture information. A product described as “fermented” may have a different nutritional role from a yoghurt, and neither description tells you whether a specific strain has been tested for your concern.

Fibre belongs in this conversation, but it is not a probiotic. Plant foods such as legumes, whole grains, fruit, vegetables, nuts, and seeds provide fibres that can be used by gut microorganisms. If you have recently increased fibre and are experiencing discomfort, gradual changes and adequate fluid intake can be easier to manage. Individual needs differ, especially with bowel conditions, so personalised advice can be worthwhile.

The important boundary is between a nourishing routine and a cure claim. Fermented food does not treat a bowel disease. A probiotic drink does not override food safety, prescribed medicines, or an assessment for red-flag symptoms. It can be part of a diet; it is not a shortcut around care.

How to read a New Zealand supplement claim

In New Zealand, dietary supplements are regulated under the Dietary Supplements Regulations 1985, which sit under the Food Act 2014. Medsafe states that there is no pre-approval process for dietary supplements. The sponsor responsible for putting a product on the market is responsible for quality, safety, and legal compliance.

That regulatory fact gives consumers a practical rule: do not mistake a product being available for a pre-market finding that it will treat your condition. A lawful-looking package can still make a broad marketing impression that goes beyond the evidence for its exact strains or dose.

Read the claim alongside the identifying information. Can you see the organism name and strain? Does the product state how many viable organisms it contains through expiry? Does it say what outcome it is for without using vague all-purpose language? Does it direct you to storage conditions and a responsible supplier? The more specific the health promise, the more specific the supporting information should be.

Be especially cautious with claims that imply a probiotic will detoxify the body, fix a “leaky gut,” eliminate bloating for everyone, treat infection, replace antibiotics, cure eczema, or manage an inflammatory bowel condition. These phrases often collapse a complex health question into a saleable bottle. If the concern is substantial enough to need a cure, it is substantial enough to deserve appropriate medical advice.

A calm checklist for the shelf and the pharmacy counter

A probiotic purchase becomes clearer when you stop looking for a universal winner. Choose the product, if you choose one, for an explicit reason and with an exit plan.

1. State the outcome you hope to address in plain words.
2. Find the full genus, species, and strain designation, not only a broad category.
3. Check the CFU amount and whether it is guaranteed through the expiry date.
4. Follow the stated storage conditions and do not buy more than you can use on time.
5. Look for human evidence on the same strain, purpose, and population.
6. Ask a pharmacist about use alongside medicines, antibiotics, pregnancy, medical conditions, or a higher-risk health situation.
7. Stop treating the product as the answer if symptoms are severe, persistent, changing, or accompanied by warning signs.

The label is not asking you to become a microbiologist. It is asking you to notice whether the product gives you enough information to make a grounded choice. A named strain, a meaningful viable count, and a modest, evidence-linked expectation are more valuable than a very large CFU number surrounded by vague promises.

Sources: NIH Office of Dietary Supplements probiotic fact sheets; Medsafe New Zealand dietary-supplement regulation guidance; FDA safety communication on probiotic products for hospitalised preterm infants; American Gastroenterological Association clinical guidance; healthdirect Australia. Accessed August 2026.

Sources

ods.od.nih.gov

ods.od.nih.gov

www.medsafe.govt.nz

www.fda.gov

www.healthdirect.gov.au

www.nhs.uk

www.cochrane.org

This article is for general education and does not replace advice from a qualified healthcare professional.